Risk Score of Embolism in Patients With AF Undergoing DOAC Therapy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorHospital Universitari Vall d'Hebron Research Institute
About this trial
Acute ischaemic strokes occur despite the use of direct oral anticoagulants (DOACs). Evidence-based scale is necessary to assess ischemic stroke risk in atrial fibrillation (AF) patients.
Eligibility criteria
Qualifiers
Patient over 18 years of age
History of AD
Currently on DOACs.
Capacity to understand the study procedures and provide informed consent.
Disqualifiers
Patient with valvular AF (mitral stenosis) or mechanical valve prostheses.
Unable to complete a follow-up period of at least 3 months from enrollment.
Trial design
Treatments tested in this trial
- DOAC Level
Treatment groups
250 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov